Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 4, 2009, Pages 368-374

  Carcillo, Joseph ^a   Holubkov, Richard ^b   Dean, J Michael ^b   Berger, John ^c   Meert, Kathleen L ^d   Anand, K J S ^e   Zimmerman, Jerry ^f   Newth, Christopher J L ^g   Harrison, Rick ^h   Willson, Douglas F ⁱ   Nicholson, Carol ^j  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^e ARKANSAS CHILDREN S HOSPITAL   (United States)

^f SEATTLE CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF VIRGINIA CHILDREN S HOSPITAL   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

Critical care; Lymphocyte function; Nosocomial infection; Prolactin; Selenium; Zinc

Indexed keywords

BENEPROTEIN; GLUTAMINE; METOCLOPRAMIDE; PLACEBO; PROTEIN; SELENIUM; UNCLASSIFIED DRUG; ZINC; ZINC CHLORIDE;

ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICAL ILLNESS STRESS INDUCED IMMUNE SUPPRESSION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG SAFETY; ENTERIC FEEDING; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MORNING DOSAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STRESS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; CROSS INFECTION; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; ENTERAL NUTRITION; GLUTAMINE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; KAPLAN-MEIERS ESTIMATE; METOCLOPRAMIDE; MILK PROTEINS; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; SELENIUM; SEPSIS; STRESS, PHYSIOLOGICAL; ZINC;

EID: 67649212136     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108327392     Document Type: Article

References (32)

1. Dallman PR White blood cells: developmental changes in numbers. In: Rudolph CD, Rudolph AM, Hoffman JIE, eds. Pediatrics. 1 9 th ed. Norwalk, CT: Appleton and Lange ; 1987 :1061.
2. Anonymous. Immunization in special clinical circumstances. In: Pickering LK, ed. Redbook: Report of the Committee of Infectious Diseases. 25 th ed. Elk Grove Village, IL: Academy of Pediatrics ; 2000: 59.
3. Stiehm ER Immunologic Disorders in Infants and Children. Philadelphia, PA: W. B. Saunders ; 1989.
4. Hotchkiss RS, Tinsley KW, Swanson PE Jr, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001 ; 166 (11). 6952-6963. (Pubitemid 32467243)
5. Gurevich P., Ben-Hur H., Czernobilsky B., Nyska A., Zuckerman A., Zusman I. Pathology of lymphoid organs in low birth weight infants subjected to antigen-related diseases: a morphological and morphometric study. Pathology. 1995 ; 27 (2). 121-126.
6. Hotchkiss RS, Chang KC, Swanson PE, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol. 2000 ; 1 (6). 496-501.
7. Zellweger R., Wichmann MW, Ayala A., Chaudry I.H. Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage. J Trauma. 1998 ; 44 (1). 70-77. (Pubitemid 28095822)
8. Zellweger R., Zhu XH, Wichmann MW, Ayala A., DeMaso CM, Chaudry IH Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol. 1996 ; 157 (12). 5748-5754. (Pubitemid 126449000)
9. Knoferl MW, Angele MK, Ayala A., Cioffi WG, Bland KI, Chaudry IH Insight into the mechanism by which metoclopramide improves immune functions after trauma-hemorrhage. Am J Physiol Cell Physiol. 2000 ; 279 (1). C72 - C80.
10. Felmet KA, Hall MW, Clark RS, Jaffe R., Carcillo JA Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol. 2005 ; 174 (6). 3765-3772. (Pubitemid 40354089)
11. Yavagal DR, Karnad DR, Oak JL Metoclopramide for preventing pneumonia in critically ill patients receiving enteral tube feeding: a randomized controlled trial. Crit Care Med. 2000 ; 28 (5). 1408-1411. (Pubitemid 30324515)
12. Brooks WA, Yunus M., Santosham M., et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet. 2004 ; 363 (9422). 1683-1688. (Pubitemid 38670325)
13. Walker CF, Black RE Zinc and the risk for infectious disease. Annu Rev Nutr. 2004 ; 24: 255-275. (Pubitemid 38949815)
14. Baqui AH, Black RE, El Arifeen S., et al. Zinc therapy for diarrhoea increased the use of oral rehydration therapy and reduced the use of antibiotics in Bangladeshi children. J Health Popul Nutr. 2004 ; 22 (4). 440-442. (Pubitemid 40104104)
15. Raqib R., Roy SK, Rahman MJ, et al. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. Am J Clin Nutr. 2004 ; 79 (3). 444-450. (Pubitemid 41115589)
16. Bhatnagar S., Bahl R., Sharma PK, Kumar GT, Saxena SK, Bhan MK Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: A randomized controlled trial. J Pediatr Gastroenterol Nutr. 2004 ; 38 (1). 34-40. (Pubitemid 39274465)
17. Sazawal S., Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics. 2001 ; 108 (6). 1280-1286. (Pubitemid 33121469)
18. Darlow BA, Austin NC Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev. 2003 ; 4: CD003312.
19. van den Berg A., van Elburg RM, Westerbeek EA, Twisk JW, Fetter WP Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. Am J Clin Nutr. 2005 ; 81 (6). 1397-1404. (Pubitemid 41710244)
20. Boelens PG, Houdijk AP, Fonk JC, et al. Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical study. Clin Nutr. 2004 ; 23 (3). 391-400.
21. Yalcin SS, Yurdakok K., Tezcan I., Oner L. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea. J Pediatr Gastroenterol Nutr. 2004 ; 38 (5). 494-501.
22. Leteurtre S., Martinot A., Duhamel A., et al. Development of a pediatric multiple organ dysfunction score: use of two strategies. Med Decis Making. 1999 ; 19 (4). 399-410. (Pubitemid 29474766)
23. Leteurtre S., Martinot A., Duhamel A., et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003 ; 362 (9379). 192-197. (Pubitemid 36859934)
24. Doughty LA, Kaplan SS, Carcillo JA Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med. 1996 ; 24 (7). 1137-1143. (Pubitemid 26249363)
25. Kim WR, Therneau TM, Benson JT, et al. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology. 2006 ; 43: 345-351. (Pubitemid 43304002)
26. Freedman LS Tables of the number of patients required in clinical trials using the logrank test. Stat Med. 1982 ; 1: 121-129. (Pubitemid 13146129)
27. Jennison C, Turnbull BW. Group Sequential Methods With Applications to Clinical Trials. Boca Raton, FL: Chapman & Hall; 2000.
28. Klein BS, Perloff WH, Maki DG Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med. 1989 ; 320 (26). 1714-1721. (Pubitemid 19163127)
29. Slota M., Green M., Farley A., Janosky J., Carcillo J. The role of gown and glove isolation and strict handwashing in the reduction of nosocomial infection in children with solid organ transplantation. Crit Care Med. 2001 ; 29 (2). 405-412. (Pubitemid 32171789)
30. Leclerc F., Leteurtre S., Duhamel A., et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med. 2005 ; 171 (4). 348-353. (Pubitemid 40223402)
31. Li P., Yin YL, Li D., Kim SW, Wu G. Amino acids and immune function. Br J Nutr. 2007 ; 98 (2). 237-252. (Pubitemid 47091364)
32. Heyland DK, Dhaliwal R., Day AG, et al, and the Canadian Critical Care Trials Group. REducing Deaths due to OXidative Stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically ill patients. Proc Nutr Soc. 2006 ; 65: 250-263. (Pubitemid 46323840)